Post-earnings recap
Reported
Mon, Mar 2, 2026
EPS actual
$0.42
EPS est.
$-0.27
EPS surprise
+255.56%
1-day move
-2.83%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Core Scientific's strong EPS performance indicates better-than-expected profitability, which is a positive sign for investors. However, the stock fell by 2.83% in reaction to the lack of revenue details and forward guidance, suggesting that investors may be concerned about future growth prospects. The management's cautious tone may also have contributed to the stock's decline.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.42 | N/A | +255.56% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a sense of cautious optimism regarding their financial performance. They highlighted the significant EPS beat as a positive indicator.
Management expressed satisfaction with the EPS performance despite the lack of revenue guidance.
They emphasized their focus on operational efficiency moving forward.